CB1 receptor

From WikiMD's WELLNESSPEDIA

CB1 receptor‏‎, also known as the cannabinoid receptor 1, is a type of G protein-coupled receptor that is primarily located in the brain and central nervous system, although it can also be found in other parts of the body. It is one of two main receptors that interact with cannabinoids, the other being the CB2 receptor.

Function[edit]

The CB1 receptor plays a crucial role in the endocannabinoid system, a biological system involved in regulating a variety of physiological and cognitive processes. When activated by a cannabinoid, the CB1 receptor can influence neurotransmitter release, thereby affecting things like pain sensation, mood, and appetite.

Ligands[edit]

Various types of ligands can bind to the CB1 receptor, including both endogenous and exogenous cannabinoids. Endogenous cannabinoids, or endocannabinoids, are naturally produced by the body and include substances like anandamide and 2-AG. Exogenous cannabinoids, on the other hand, are those introduced to the body from external sources, such as cannabis.

Clinical significance[edit]

Due to its role in the endocannabinoid system, the CB1 receptor is a target for a number of therapeutic applications. For example, drugs that activate the CB1 receptor can be used to treat pain, while those that block the receptor can be used to treat obesity. However, the use of such drugs can also have side effects, such as the psychoactive effects associated with cannabis use.

See also[edit]



This GPCR-related article is a stub. You can help WikiMD by expanding it.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.